---
title: "Aytu BioPharma GAAP EPS of $0.00 beats by $0.33, revenue of $16.1M beats by $3.82M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299810027.md"
description: "Aytu BioPharma GAAP EPS of $0.00 beats by $0.33, revenue of $16.1M beats by $3.82M"
datetime: "2026-09-22T20:30:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299810027.md)
  - [en](https://longbridge.com/en/news/299810027.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299810027.md)
generator: "portal-rs"
---

# Aytu BioPharma GAAP EPS of $0.00 beats by $0.33, revenue of $16.1M beats by $3.82M


### Related Stocks

- [AYTU.US](https://longbridge.com/en/quote/AYTU.US.md)

## Related News & Research

- [Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales](https://longbridge.com/en/news/299809035.md)
- [AYTU: EXXUA launch drives growth in CNS therapeutics, with FY26 revenue at $66.4M](https://longbridge.com/en/news/299813775.md)
- [Nvidia-Backed Robotics Startup FieldAI Hits $10 Billion Valuation After $700 Million Raise, More Than Quadrupling Value in Just Over a Year: Report](https://longbridge.com/en/news/300845294.md)
- [Nike Just Reported Earnings. Here's What Investors Need to Know.](https://longbridge.com/en/news/300813690.md)
- [Time to Nibble on MCD Stock After it Enters Oversold Territory?](https://longbridge.com/en/news/300812314.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**